Plunkett Research Online: Medicure Inc

MEDICURE INC (MPH:TSX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Medicure, Inc. is a specialty pharmaceutical company involved in research, clinical development and commercialization of human therapeutics. The company is dedicated to exclusively marketing its FDA approved small molecule, AGGRASTAT. The drug is indicated to reduce the rate of thrombotic cardiovas.....



Medicure Inc
Ticker: MPH
Exchange: TSX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 204 487-7412
Fax: 204 488-9823
Address: 2-1250 Waverley Street
Winnipeg, MB R3T 6C6 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Albert FriesenCEO/Chairman of the Board/Director/Founder/President
James KinleyCFO/Secretary
See More
Medicure, Inc. is a specialty pharmaceutical company involved in research, clinical development and commercialization of human therapeutics. The company is dedicated to exclusively marketing its FDA approved small molecule, AGGRASTAT. The drug is indicated to reduce the rate of thrombotic cardiovas.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
AGGRASTAT
Medicure International Inc (Barbados)
Medicure Pharma Inc
Apicore US LLC
AGGRASTAT tirofiban HCI
Tardoxal
AGGRADERM tirofiban HCI
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: